Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
Journal
-
- The Lancet Gastroenterology & Hepatology
-
The Lancet Gastroenterology & Hepatology 7 (3), 208-218, 2022-03
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360580934799898496
-
- ISSN
- 24681253
-
- Data Source
-
- Crossref